Last €17.56 EUR
Change Today +1.57 / 9.80%
Volume 0.0
NU2 On Other Exchanges
Symbol
Exchange
Frankfurt
As of 2:16 AM 11/24/14 All times are local (Market data is delayed by at least 15 minutes).

nutraceutical intl corp (NU2) Snapshot

Open
€17.56
Previous Close
€15.99
Day High
€17.56
Day Low
€17.56
52 Week High
04/8/14 - €20.01
52 Week Low
10/2/14 - €15.94
Market Cap
169.3M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
9.6M
EX-Date
12/19/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NUTRACEUTICAL INTL CORP (NU2)

Related News

No related news articles were found.

nutraceutical intl corp (NU2) Related Businessweek News

No Related Businessweek News Found

nutraceutical intl corp (NU2) Details

Nutraceutical International Corporation manufactures, markets, distributes, and retails branded nutritional supplements and other natural products in the United States and internationally. It offers vitamins and minerals, herbs, specialty formulas, personal care products, homeopathics, functional foods, and other products in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, creams, sprays, powders, and whole herbs. The company sells its products under the Solaray, KAL, Nature’s Life, LifeTime, Natural Balance, bioAllers, Herbs for Kids, NaturalCare, Health from the Sun, Life-flo, Organix South, Pioneer, and Monarch Nutraceuticals brands. It also owns neighborhood natural food markets, which operate under the trade names The Real Food Company, Thom’s Natural Foods, and Cornucopia Community Market; and health food stores that operate under various trade names, including Fresh Vitamins, Granola’s, Nature’s Discount, and Warehouse Vitamins. The company sells its products primarily to and through health and natural food stores, distributors, retailers, and others, as well as directly to consumers. Nutraceutical International Corporation was founded in 1993 and is based in Park City, Utah.

Founded in 1993

nutraceutical intl corp (NU2) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.1M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $439.7K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $536.5K
Vice President of Legal Affairs and Assistant...
Total Annual Compensation: $509.7K
Vice President of Marketing & Sales
Total Annual Compensation: $364.8K
Compensation as of Fiscal Year 2013.

nutraceutical intl corp (NU2) Key Developments

Nutraceutical International Increases Credit Line

Nutraceutical International Corporation has closed on an amended revolving credit facility, with Rabobank International continuing as lead bank under the facility. Wells Fargo will also remain as a lender and is currently Nutraceutical's primary US commercial banking partner. This amended credit facility extends the term of the line of credit to November 2019, increases the ongoing commitment from $90 million to $100 million and provides an additional accordion feature to increase the commitment up to $130 million, subject to certain conditions.

Nutraceutical International Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2014

Nutraceutical International Corporation announced unaudited consolidated earnings results for the third quarter and nine months ended June 30, 2014. For the quarter, the company reported net sales of $55,625,000 compared to $50,814,000 a year ago. Income from operations was $6,686,000 compared to $6,427,000 a year ago. Income before provision for income taxes was $6,330,000 compared to $6,091,000 a year ago. Net income was $3,997,000 or $0.41 per basic and diluted common share compared to $3,842,000 or $0.39 per basic and diluted common share a year ago. Adjusted EBITDA was $9,628,000 compared to $8,913,000 a year ago. For the nine months, the company reported net sales of $162,034,000 compared to $157,141,000 a year ago. Income from operations was $20,809,000 compared to $21,145,000 a year ago. Income before provision for income taxes was $19,785,000 compared to $20,121,000 a year ago. Net income was $12,456,000 or $1.27 per diluted common share compared to $12,872,000 or $1.31 per diluted common share a year ago. Adjusted EBITDA was $29,166,000 compared to $28,470,000 a year ago. Operating cash flow for the nine months ended June 30, 2014 was $16.1 million compared to $19.2 million for the same period of fiscal 2013. The operating cash flow for the nine months ended June 30, 2014, combined with net borrowings of $9.0 million and existing cash, was primarily used to invest $16.2 million in acquisitions of natural product businesses, $8.6 million in purchases of property, plant and equipment and $3.8 million in purchases of common stock for treasury.

Nutraceutical International Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended March 31, 2014

Nutraceutical International Corporation reported unaudited consolidated earnings results for the second quarter and six months ended March 31, 2014. For the quarter, the company reported income from operations of $7,226,000, income before provision for income taxes of $6,876,000, net income of $4,324,000 or $0.44 per basic and diluted share on net sales of $54,859,000 against income from operations of $8,913,000, income before provision for income taxes of $8,536,000, net income of $5,536,000 or $0.57 per basic and diluted share on net sales of $56,583,000 for the same period a year ago. Adjusted EBITDA was $10,003,000 against $11,350,000 for the same period a year ago. Decreases in net income and Adjusted EBITDA for the second quarter of fiscal 2014 primarily resulted from the net sales decline and an increase in selling, general and administrative expenses related to acquisitions. For the six months, the company reported income from operations of $14,123,000, income before provision for income taxes of $13,455,000, net income of $8,459,000 or $0.86 per basic and diluted share on net sales of $106,409,000 against income from operations of $14,718,000, income before provision for income taxes of $14,030,000, net income of $9,030,000 or $0.92 per basic and diluted share on net sales of $106,327,000 for the same period a year ago. Adjusted EBITDA was $19,538,000 against $19,557,000 for the same period a year ago. Operating cash flow for the six months ended March 31, 2014 was $10.8 million compared to $15.1 million for the same period of fiscal 2013. The operating cash flow for the six months ended March 31, 2014, combined with net borrowings of $4.0 million and existing cash, was primarily used to invest $9.1 million in acquisitions of natural product businesses, $6.4 million in purchases of property, plant and equipment and $1.4 million in purchases of common stock for treasury.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NU2:GR €17.56 EUR +1.57

NU2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aceto Corp $21.04 USD -0.15
GNC Holdings Inc $44.36 USD -0.74
Nature's Sunshine Products Inc $15.10 USD -0.01
USANA Health Sciences Inc $107.72 USD +0.47
Vitamin Shoppe Inc $47.24 USD -0.54
View Industry Companies
 

Industry Analysis

NU2

Industry Average

Valuation NU2 Industry Range
Price/Earnings 13.4x
Price/Sales 1.0x
Price/Book 1.4x
Price/Cash Flow 11.3x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NUTRACEUTICAL INTL CORP, please visit www.nutraceutical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.